Director EP - Search Results

1

Cytokine regulation of tumor necrosis factor-alpha and -beta (lymphotoxin)-messenger RNA expression in human peripheral blood mononuclear cells.

Kasid A, Director EP, Stovroff MC, Lotze MT, Rosenberg SA. Kasid A, et al. Among authors: director ep. Cancer Res. 1990 Aug 15;50(16):5072-6. Cancer Res. 1990. PMID: 1696166

2

The local effects of cachectin/tumor necrosis factor on wound healing.

Salomon GD, Kasid A, Cromack DT, Director E, Talbot TL, Sank A, Norton JA. Salomon GD, et al. Ann Surg. 1991 Aug;214(2):175-80. doi: 10.1097/00000658-199108000-00012. Ann Surg. 1991. PMID: 1714269 Free PMC article.

3

Human gene transfer: characterization of human tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in man.

Kasid A, Morecki S, Aebersold P, Cornetta K, Culver K, Freeman S, Director E, Lotze MT, Blaese RM, Anderson WF, et al. Kasid A, et al. Proc Natl Acad Sci U S A. 1990 Jan;87(1):473-7. doi: 10.1073/pnas.87.1.473. Proc Natl Acad Sci U S A. 1990. PMID: 2404283 Free PMC article.

4

Induction of endogenous cytokine-mRNA in circulating peripheral blood mononuclear cells by IL-2 administration to cancer patients.

Kasid A, Director EP, Rosenberg SA. Kasid A, et al. Among authors: director ep. J Immunol. 1989 Jul 15;143(2):736-9. J Immunol. 1989. PMID: 2661690

5

Gene expression in normal and doxorubicin-impaired wounds: importance of transforming growth factor-beta.

Salomon GD, Kasid A, Bernstein E, Buresh C, Director E, Norton JA. Salomon GD, et al. Surgery. 1990 Aug;108(2):318-22; discussion 322-3. Surgery. 1990. PMID: 2382227

6

Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.

Kasid A, Bell GI, Director EP. Kasid A, et al. Among authors: director ep. J Immunol. 1988 Jul 15;141(2):690-8. J Immunol. 1988. PMID: 3133414

7

Studies of serum-free culture medium in the generation of lymphokine activated killer cells.

Muul LM, Nason-Burchenal K, Hyatt C, Schwarz S, Slavin D, Director EP, Rosenberg SA. Muul LM, et al. Among authors: director ep. J Immunol Methods. 1987 Dec 24;105(2):183-92. doi: 10.1016/0022-1759(87)90265-1. J Immunol Methods. 1987. PMID: 3693906

8

Large scale production of human lymphokine activated killer cells for use in adoptive immunotherapy.

Muul LM, Director EP, Hyatt CL, Rosenberg SA. Muul LM, et al. Among authors: director ep. J Immunol Methods. 1986 Apr 17;88(2):265-75. doi: 10.1016/0022-1759(86)90015-3. J Immunol Methods. 1986. PMID: 3485692

9

Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma.

Muul LM, Spiess PJ, Director EP, Rosenberg SA. Muul LM, et al. Among authors: director ep. J Immunol. 1987 Feb 1;138(3):989-95. J Immunol. 1987. PMID: 3100623

10

Development of an automated closed system for generation of human lymphokine-activated killer (LAK) cells for use in adoptive immunotherapy.

Muul LM, Nason-Burchenal K, Carter CS, Cullis H, Slavin D, Hyatt C, Director EP, Leitman SF, Klein HG, Rosenberg SA. Muul LM, et al. Among authors: director ep. J Immunol Methods. 1987 Aug 3;101(2):171-81. doi: 10.1016/0022-1759(87)90148-7. J Immunol Methods. 1987. PMID: 3611795

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters